157 related articles for article (PubMed ID: 28812799)
1. Current Models of Investor State Dispute Settlement Are Bad for Health: The European Union Could Offer an Alternative Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?".
McKee M; Stuckler D
Int J Health Policy Manag; 2017 Mar; 6(3):177-179. PubMed ID: 28812799
[TBL] [Abstract][Full Text] [Related]
2. Is It Time to Say Farewell to the ISDS System? Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?".
Lencucha R
Int J Health Policy Manag; 2017 May; 6(5):289-291. PubMed ID: 28812817
[TBL] [Abstract][Full Text] [Related]
3. The Trans-Pacific Partnership: Is It Everything We Feared for Health?
Labonté R; Schram A; Ruckert A
Int J Health Policy Manag; 2016 Aug; 5(8):487-496. PubMed ID: 27694662
[TBL] [Abstract][Full Text] [Related]
4. The Trans-Pacific Partnership: Should We "Fear the Fear"? Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?".
Walls HL; Hanefeld J; Smith RD
Int J Health Policy Manag; 2017 Jun; 6(6):353-355. PubMed ID: 28812829
[TBL] [Abstract][Full Text] [Related]
5. Advancing Public Health on the Changing Global Trade and Investment Agenda Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?".
Thow AM; Gleeson D
Int J Health Policy Manag; 2017 May; 6(5):295-298. PubMed ID: 28812819
[TBL] [Abstract][Full Text] [Related]
6. Trade Policy and Health: Adding Retrospective Studies to the Research Agenda Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?".
Blouin C
Int J Health Policy Manag; 2017 Apr; 6(4):243-244. PubMed ID: 28812809
[TBL] [Abstract][Full Text] [Related]
7. Assessing the Health Impact of Trade: A Call for an Expanded Research Agenda Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?".
McNamara C
Int J Health Policy Manag; 2017 May; 6(5):293-294. PubMed ID: 28812818
[TBL] [Abstract][Full Text] [Related]
8. Harnessing trade and investment agreements to promote public health.
Janardhan S
Drug Alcohol Rev; 2021 Jan; 40(1):41-49. PubMed ID: 32840009
[TBL] [Abstract][Full Text] [Related]
9. Just Say No to the TPP: A Democratic Setback for American and Asian Public Health Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?".
Muntaner C; Mahabir DF
Int J Health Policy Manag; 2017 Jul; 6(7):419-421. PubMed ID: 28812839
[TBL] [Abstract][Full Text] [Related]
10. The Trans-Pacific Partnership Agreement: Trading away our health?
Ruckert A; Schram A; Labonté R
Can J Public Health; 2015 Apr; 106(4):e249-51. PubMed ID: 26285198
[TBL] [Abstract][Full Text] [Related]
11. A Corporate Veto on Health Policy? Global Constitutionalism and Investor-State Dispute Settlement.
Hawkins B; Holden C
J Health Polit Policy Law; 2016 Oct; 41(5):969-95. PubMed ID: 27256810
[TBL] [Abstract][Full Text] [Related]
12. The Potential Impact of the Transatlantic Trade and Investment Partnership (TTIP) on public health.
De Vogli R; Renzetti N
Epidemiol Prev; 2016; 40(2):95-102. PubMed ID: 27290886
[TBL] [Abstract][Full Text] [Related]
13. The Trans-Pacific Partnership Agreement and health: few gains, some losses, many risks.
Labonté R; Schram A; Ruckert A
Global Health; 2016 Jun; 12(1):25. PubMed ID: 27265351
[TBL] [Abstract][Full Text] [Related]
14. The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia.
Lexchin J; Gleeson D
Int J Health Serv; 2016 Oct; 46(4):597-613. PubMed ID: 27516183
[TBL] [Abstract][Full Text] [Related]
15. To what extent does a tobacco carve-out protect public health in the Trans-Pacific Partnership Agreement?
Hirono K; Gleeson D; Freeman B
Public Health Res Pract; 2016 Apr; 26(2):. PubMed ID: 27734065
[TBL] [Abstract][Full Text] [Related]
16. Is health impact assessment useful in the context of trade negotiations? A case study of the Trans Pacific Partnership Agreement.
Hirono K; Haigh F; Gleeson D; Harris P; Thow AM; Friel S
BMJ Open; 2016 Apr; 6(4):e010339. PubMed ID: 27044579
[TBL] [Abstract][Full Text] [Related]
17. Do international trade and investment agreements generate regulatory chill in public health policymaking? A case study of nutrition and alcohol policy in South Africa.
Milsom P; Smith R; Modisenyane SM; Walls H
Global Health; 2021 Sep; 17(1):104. PubMed ID: 34488811
[TBL] [Abstract][Full Text] [Related]
18. USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health.
Labonté R; Crosbie E; Gleeson D; McNamara C
Global Health; 2019 May; 15(1):35. PubMed ID: 31088499
[TBL] [Abstract][Full Text] [Related]
19. Trade Agreements and Direct-to-Consumer Advertising of Pharmaceuticals.
Gleeson D; Menkes DB
Int J Health Policy Manag; 2018 Feb; 7(2):98-100. PubMed ID: 29524933
[TBL] [Abstract][Full Text] [Related]
20. A new generation of trade policy: potential risks to diet-related health from the trans pacific partnership agreement.
Friel S; Gleeson D; Thow AM; Labonte R; Stuckler D; Kay A; Snowdon W
Global Health; 2013 Oct; 9():46. PubMed ID: 24131595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]